IAS 2013: Lower-dose Efavirenz as Effective as Standard Dose [VIDEO]
- Details
- Category: HIV Treatment
- Published on Monday, 08 July 2013 00:00
- Written by Gregory Fowler
Lowering the dosage of efavirenz (Sustiva) from 600 mg to 400 mg did not compromise its effectiveness, according to data from the ENCORE1 study presented at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) this week in Kuala Lumpur.
IAS 2013: Early Testing and Treatment Linked to Lower Sexual Risk in Thai Study [VIDEO]
- Details
- Category: HIV Prevention
- Published on Monday, 08 July 2013 00:00
- Written by Gregory Fowler
Gay men who started antiretroviral treatment during acute HIV infection achieved good viral load suppression in both blood and semen, and also reported reduced sexual risk behavior, researchers reported at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) this week in Kuala Lumpur.
IAS 2013: No Increase in Risk Behavior among People Taking ART, Meta-Analysis Shows
- Details
- Category: HIV Prevention
- Published on Sunday, 07 July 2013 00:00
- Written by Roger Pebody
One of the anxieties in relation to treatment as prevention is that it may discourage people with HIV from using condoms and other prevention methods. However, a meta-analysis has found no increase in risk-taking among people taking antiretroviral treatment, researchers reported at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) this week in Kuala Lumpur last week.
IAS 2013: Studies Look at Second-Line Bone Changes, Fractures, and HIV- and HCV-Related Bone Loss
- Details
- Category: Bone Loss
- Published on Sunday, 07 July 2013 00:00
- Written by Liz Highleyman
People with HIV experience less bone loss if they switch to a NRTI-sparing second-line regimen containing raltegravir, researchers reported last week at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) this week in Kuala Lumpur. Other studies showed that HIV infection is associated with increased risk of hip fractures and shed light on different mechanisms of bone loss associated with HIV and hepatitis C.
HIV Treatment Highlights from IAS 2013 [VIDEO]
- Details
- Category: HIV Treatment
- Published on Sunday, 07 July 2013 00:00
- Written by Gregory Fowler
Cal Cohen offers a summary of some of the major studies of antiretroviral treatment strategies presented at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) last week in Kuala Lumpur.
More Articles...
- IAS 2013: Second-line HIV Therapy with NRTIs Linked to Bone Loss [VIDEO]
- IAS 2013: Switch to Etravirine Maintains Viral Suppression and Improves Lipid Levels
- Coverage of the 2013 International AIDS Society Conference
- IAS 2013: Long-acting GSK1265744 and TMC278-LA Appear Safe and Practical in Early Study
Web Design and Development by